TY  - GEN
AU  - Grimwade,David
AU  - Jovanovic,Jelena V
AU  - Hills,Robert K
AU  - Nugent,Elizabeth A
AU  - Patel,Yashma
AU  - Flora,Rajinder
AU  - Diverio,Daniela
AU  - Jones,Katy
AU  - Aslett,Hannah
AU  - Batson,Elaine
AU  - Rennie,Kristian
AU  - Angell,Roger
AU  - Clark,Richard E
AU  - Solomon,Ellen
AU  - Lo-Coco,Francesco
AU  - Wheatley,Keith
AU  - Burnett,Alan K
TI  - Prospective minimal residual disease monitoring to predict relapse of acute promyelocytic leukemia and to direct pre-emptive arsenic trioxide therapy
SN  - 1527-7755
PY  - 2009///0820
KW  - Adult
KW  - Aged
KW  - Arsenic Trioxide
KW  - Arsenicals
KW  - administration & dosage
KW  - Blood Chemical Analysis
KW  - Bone Marrow
KW  - pathology
KW  - Cohort Studies
KW  - Confidence Intervals
KW  - Female
KW  - Gene Expression Regulation, Neoplastic
KW  - Humans
KW  - Leukemia, Promyelocytic, Acute
KW  - drug therapy
KW  - Male
KW  - Middle Aged
KW  - Monitoring, Physiologic
KW  - methods
KW  - Multivariate Analysis
KW  - Neoplasm Recurrence, Local
KW  - diagnosis
KW  - Neoplasm, Residual
KW  - Oncogene Proteins, Fusion
KW  - genetics
KW  - Oxides
KW  - Predictive Value of Tests
KW  - Probability
KW  - Prognosis
KW  - Proportional Hazards Models
KW  - Prospective Studies
KW  - Reverse Transcriptase Polymerase Chain Reaction
KW  - Severity of Illness Index
KW  - Survival Analysis
KW  - Treatment Outcome
KW  - Tretinoin
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1200/JCO.2008.20.1533
ER  -